Announcement on Implementation of Dividend Distribution for 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Implementation of Dividend Distribution for 2025
Filed with SSE · · 4 pages · Chinese
Release
Beijing Sun-Novo Pharmaceutical Research Co. Ltd. on 6ix
Earlier from Beijing Sun-Novo Pharmaceutical Research
- Announcement on Participation in the Establishment of Hangzhou Qizhen Zhikang Equity Investment Partnership (Limited Partnership)
- Announcement on Progress in Signing of the "Supplementary Agreement to the Technology Development Contract" for STC008 Injection
- Announcement on Voluntary Disclosure on the Acceptance of Clinical Trial Application for STC009 Injection
- Announcement on Completion of the Board of Directors' Re-election, Election of the Chairman and Members of Special Committees under the Board of Directors, and Appointment of Senior Management Member and Securities Affairs Representative
- Announcement on Progress in Cooperation in Investment with a Private Fund
Later from Beijing Sun-Novo Pharmaceutical Research
- Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report
- Special Report on the Use of Previously Raised Funds
- Announcement of Voluntary Disclosure of Semi-annual Performance Forecast for 2026
- Indicative Announcement on the Transfer by Agreement of Certain Shares of the Company by the Controlling Shareholder and the Actual Controller, and the Resulting Change in Equity Interests
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Follow Beijing Sun-Novo Pharmaceutical Research into a list and get an email when it puts out news.
Follow Beijing Sun-Novo Pharmaceutical Research